S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signalingFeyza Gül Özbay Kurt(German Cancer Research Center), Viktor Umansky(German Cancer Research Center)Journal for ImmunoTherapy of CancerAugust 1, 202410.1136/jitc-2024-009552Cited by 39SaveCiteExport RISWatch citationsRelated PapersMyeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors|Frontiers in Immunology|2018|548von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans|Blood|2015|159